Choriogonadotropin alfa biosimilar (Suzhou AlphaMab)

绒促性素α生物类似药（苏州康宁杰瑞生物科技）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameChoriogonadotropin alfa biosimilar (Suzhou AlphaMab)
Drug Alias Name绒促性素α生物仿制药（苏州康宁杰瑞生物科技）KN-017
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionLuteinizing hormone/Choriogonadotropin receptor agonists
TargetsLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsInfertility, FemalePolycystic Ovary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Alphamab Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Alphamab Co Ltd
Inactive CompaniesN/A
Active IndicationsInfertility, FemalePolycystic Ovary Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeG03GA08
Related LinksN/A